Correction to “Stem cells technology as a platform for generating reproductive system organoids and treatment of infertility-related diseases”

IF 3.3 3区生物学 Q3 CELL BIOLOGY

Cell Biology International Pub Date : 2024-07-04 DOI:10.1002/cbin.12217

引用次数: 0

Abstract

Jahanbani Y, Shafiee S, Davaran S, Roshangar L, Ahmadian E, Eftekhari A, Dolati S, Yousefi M. Stem cells technology as a platform for generating reproductive system organoids and treatment of infertility-related diseases. Cell Biol Int. 2022;46(4):512-522. https://doi.org/10.1002/cbin.11747

At the end of the article, Acknowledgment section, the text “This study was supported by stem cell research center at Tabriz University of Medical Sciences, Iran.” was incorrect. This should have read: “This work was supported by the Tabriz University of Medical Science-Department of Medicinal Chemistry, Pharmacy School- (Grant No. 64761).”

We apologize for this error.

查看原文本刊更多论文

更正 "干细胞技术作为生成生殖系统器官组织和治疗不孕不育相关疾病的平台"。

Jahanbani Y，Shafiee S，Davaran S，Roshangar L，Ahmadian E，Eftekhari A，Dolati S，Yousefi M.干细胞技术作为生成生殖系统器官组织和治疗不孕不育相关疾病的平台。Cell Biol Int. 2022;46(4):512-522. https://doi.org/10.1002/cbin.11747At 文章末尾，致谢部分，"本研究得到伊朗大不里士医科大学干细胞研究中心的支持 "有误。应改为"这项工作得到了大不里士医科大学药学院药物化学系的支持（拨款号：64761）。"我们对此错误深表歉意。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cell Biology International 生物-细胞生物学

CiteScore

7.60

自引率

0.00%

发文量

208

审稿时长

1 months

期刊介绍： Each month, the journal publishes easy-to-assimilate, up-to-the minute reports of experimental findings by researchers using a wide range of the latest techniques. Promoting the aims of cell biologists worldwide, papers reporting on structure and function - especially where they relate to the physiology of the whole cell - are strongly encouraged. Molecular biology is welcome, as long as articles report findings that are seen in the wider context of cell biology. In covering all areas of the cell, the journal is both appealing and accessible to a broad audience. Authors whose papers do not appeal to cell biologists in general because their topic is too specialized (e.g. infectious microbes, protozoology) are recommended to send them to more relevant journals. Papers reporting whole animal studies or work more suited to a medical journal, e.g. histopathological studies or clinical immunology, are unlikely to be accepted, unless they are fully focused on some important cellular aspect. These last remarks extend particularly to papers on cancer. Unless firmly based on some deeper cellular or molecular biological principle, papers that are highly specialized in this field, with limited appeal to cell biologists at large, should be directed towards journals devoted to cancer, there being very many from which to choose.